Sort   by:  
 Page size 
UnknownImpact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.).
Not available
S-EPMC7531828 | biostudies-literature
UnknownIdentification of l-Tryptophan by down-field 1 H MRS: A precursor for brain NAD+ and serotonin syntheses.
Not available
S-EPMC10165892 | biostudies-literature
UnknownIntrinsic subtypes, PIK3CA mutation, and the degree of benefit from adjuvant trastuzumab in the NSABP B-31 trial.
Not available
S-EPMC4397278 | biostudies-literature
UnknownRed clover (Trifolium pratense L.) draft genome provides a platform for trait improvement.
Not available
S-EPMC4663792 | biostudies-literature
UnknownIntegrating a newly developed BAC-based physical mapping resource for Lolium perenne with a genome-wide association study across a L. perenne European ecotype collection identifies genomic contexts associated with agriculturally important traits.
Not available
S-EPMC6589518 | biostudies-literature
UnknownHepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study.
Not available
S-EPMC5498308 | biostudies-literature
UnknownDefinitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
Not available
S-EPMC3757290 | biostudies-literature
UnknownLong-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
Not available
S-EPMC5721228 | biostudies-literature
UnknownAnthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology).
Not available
S-EPMC5549453 | biostudies-literature
UnknownSeven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
Not available
S-EPMC3478574 | biostudies-literature
Sort   by:  
 Page size